Iams, Wade T.
Konduri, Kartik
Funding for this research was provided by:
EMD Serono
Article History
Received: 25 April 2023
Accepted: 22 August 2023
First Online: 1 October 2023
Declarations
:
: Wade T. Iams: Consulting or advisory role – Sanofi, Elevation Oncology, AstraZeneca, NovoCure, Catalyst, Janssen, Takeda, Bristol Myers Squibb, Mirati, Chardan Consulting, Curio Science, Defined Health, G1 Therapeutics, Genentech, Jazz Pharmaceuticals, Outcomes Insights, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany. Kartik Konduri: Consultant, advisory role and speaker – AstraZeneca, Jazz Pharmaceuticals, Lilly, Bristol Myers Squibb, Amgen, Takeda, Mirati, Janssen, Curio Science, MD Outlook, Daiichi Sanyo.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.